Package 80425-0461-3

{"route": ["ORAL"], "spl_id": "29a6ba45-03f1-8b4d-e063-6394a90a9815", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["29a6c6e3-f30f-6541-e063-6394a90ae11d"], "manufacturer_name": ["Advanced Rx of Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0461-1)", "package_ndc": "80425-0461-1", "marketing_start_date": "20241218"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0461-2)", "package_ndc": "80425-0461-2", "marketing_start_date": "20241218"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0461-3)", "package_ndc": "80425-0461-3", "marketing_start_date": "20241218"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "80425-0461_29a6ba45-03f1-8b4d-e063-6394a90a9815", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "80425-0461", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Advanced Rx of Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20241218", "listing_expiration_date": "20261231"}